EAACI Congress 2026 takes place in Istanbul Türkiye from 12 to 15 June under the theme Vision Zero A Future Free from Allergy and Asthma Burden marking 70 years of the European Academy of Allergy and Clinical Immunology
Aaron Robinson presents Airmid allergen testing science in Istanbul as the global allergy community gathers under the Vision Zero theme
What if we could move closer to a future where allergy and asthma no longer place such a significant burden on people’s lives?
That ambition sits at the heart of the European Academy of Allergy and Clinical Immunology (EAACI) Congress 2026, taking place in Istanbul, Türkiye, under the theme “Vision Zero: A Future Free from Allergy and Asthma Burden.”
Allergen Testing at the Heart of EAACI 2026
At Airmid Healthgroup, this vision resonates strongly with the allergen testing work we do every day. Understanding environmental exposures, improving indoor environments, and generating high-quality scientific evidence are all essential steps towards reducing the impact of allergic and respiratory disease.
We are delighted that Aaron Robinson, Scientific Officer (Allergen Lab), will be presenting Airmid research at EAACI 2026.
Aaron leads our allergen, parasitology, and entomology research programmes, overseeing projects that investigate allergen exposure, environmental risk factors, and practical approaches to improving indoor environmental health. His work supports Airmid’s commitment to delivering independent scientific evidence that helps inform industry, healthcare, and consumers alike.
EAACI Congress 2026
📍 Istanbul, Türkiye
📅 12–15 June 2026
🎓 Celebrating EAACI’s 70th Anniversary
Poster Presentation
Presenter: Aaron Robinson
Scientific Officer – Allergen
Poster Reference: D3.472
We are excited to contribute to the wider scientific dialogue taking place at EAACI. The congress provides an important platform for discussing how innovation, environmental science, diagnostics, allergen testing, prevention strategies, and collaboration can help shape healthier futures.
Alongside the scientific programme, the airmid team looks forward to engaging with researchers, clinicians, industry leaders, and organisations working across allergy diagnostics, immunotherapy, respiratory health, environmental monitoring, and clinical research. Events such as EAACI create valuable opportunities to exchange ideas, build partnerships, and explore emerging technologies that can support better outcomes for patients worldwide.
How Airmid Supports Vision Zero
As we prepare for Istanbul, several themes continue to guide our work:
• Better evidence leads to better decisions.
• Indoor environments play a critical role in health.
• Understanding allergen exposure is fundamental to prevention.
• Collaboration accelerates scientific progress.
We are proud to see Aaron representing airmid on the international stage and contributing to the global effort to reduce the burden of allergy and asthma.
We look forward to connecting with colleagues, collaborators, and new partners at EAACI 2026.
